Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ajinomoto Co. Inc.
DescriptionOrally administered, cross-linked enzyme crystal formulation of a phenylalanine degrading enzyme
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationPhenylketonuria
Indication DetailsTreat phenylketonuria (PKU)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today